184 related articles for article (PubMed ID: 12468013)
1. The role of in vivo molecular imaging with PET and SPECT in the elucidation of psychiatric drug action and new drug development.
Talbot PS; Laruelle M
Eur Neuropsychopharmacol; 2002 Dec; 12(6):503-11. PubMed ID: 12468013
[TBL] [Abstract][Full Text] [Related]
2. Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology.
Kasper S; Tauscher J; Willeit M; Stamenkovic M; Neumeister A; Küfferle B; Barnas C; Stastny J; Praschak-Rieder N; Pezawas L; de Zwaan M; Quiner S; Pirker W; Asenbaum S; Podreka I; Brücke T
World J Biol Psychiatry; 2002 Jul; 3(3):133-46. PubMed ID: 12478878
[TBL] [Abstract][Full Text] [Related]
3. Cortical dopamine D2/D3 receptors are a common site of action for antipsychotic drugs--an original patient data meta-analysis of the SPECT and PET in vivo receptor imaging literature.
Stone JM; Davis JM; Leucht S; Pilowsky LS
Schizophr Bull; 2009 Jul; 35(4):789-97. PubMed ID: 18303092
[TBL] [Abstract][Full Text] [Related]
4. A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy.
Kapur S; Zipursky R; Jones C; Shammi CS; Remington G; Seeman P
Arch Gen Psychiatry; 2000 Jun; 57(6):553-9. PubMed ID: 10839333
[TBL] [Abstract][Full Text] [Related]
5. A new framework for investigating antipsychotic action in humans: lessons from PET imaging.
Kapur S
Mol Psychiatry; 1998 Mar; 3(2):135-40. PubMed ID: 9577837
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.
Seeman P; Tallerico T
Mol Psychiatry; 1998 Mar; 3(2):123-34. PubMed ID: 9577836
[TBL] [Abstract][Full Text] [Related]
7. Contribution of SPECT measurements of D2 and 5-HT2A occupancy to the clinical development of the antipsychotic SB-773812.
Catafau AM; Bullich S; Nucci G; Burgess C; Gray F; Merlo-Pich E;
J Nucl Med; 2011 Apr; 52(4):526-34. PubMed ID: 21421726
[TBL] [Abstract][Full Text] [Related]
8. [Molecular imaging in the drug development of psychotropics using positron emission tomography].
Takano H; Takahashi H; Ito H; Suhara T
Brain Nerve; 2007 Mar; 59(3):215-20. PubMed ID: 17370647
[TBL] [Abstract][Full Text] [Related]
9. Atypical antipsychotics: mechanism of action.
Seeman P
Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
[TBL] [Abstract][Full Text] [Related]
10. Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patients.
Bressan RA; Erlandsson K; Jones HM; Mulligan R; Flanagan RJ; Ell PJ; Pilowsky LS
Am J Psychiatry; 2003 Aug; 160(8):1413-20. PubMed ID: 12900302
[TBL] [Abstract][Full Text] [Related]
11. [Receptor occupancy and antipsychotic drug action measured by PET and SPECT].
Okubo Y; Suhara T
Seishin Shinkeigaku Zasshi; 2001; 103(4):329-40. PubMed ID: 11392846
[TBL] [Abstract][Full Text] [Related]
12. A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone.
Mamo D; Kapur S; Shammi CM; Papatheodorou G; Mann S; Therrien F; Remington G
Am J Psychiatry; 2004 May; 161(5):818-25. PubMed ID: 15121646
[TBL] [Abstract][Full Text] [Related]
13. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis.
Kapur S; Seeman P
Am J Psychiatry; 2001 Mar; 158(3):360-9. PubMed ID: 11229973
[TBL] [Abstract][Full Text] [Related]
14. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
Kapur S; Zipursky RB; Remington G
Am J Psychiatry; 1999 Feb; 156(2):286-93. PubMed ID: 9989565
[TBL] [Abstract][Full Text] [Related]
15. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate.
Volkow ND; Wang GJ; Fowler JS; Gatley SJ; Logan J; Ding YS; Hitzemann R; Pappas N
Am J Psychiatry; 1998 Oct; 155(10):1325-31. PubMed ID: 9766762
[TBL] [Abstract][Full Text] [Related]
16. Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients.
Nyberg S; Eriksson B; Oxenstierna G; Halldin C; Farde L
Am J Psychiatry; 1999 Jun; 156(6):869-75. PubMed ID: 10360125
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study.
Mamo D; Graff A; Mizrahi R; Shammi CM; Romeyer F; Kapur S
Am J Psychiatry; 2007 Sep; 164(9):1411-7. PubMed ID: 17728427
[TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography study of pindolol occupancy of 5-HT(1A) receptors in humans: preliminary analyses.
Martinez D; Mawlawi O; Hwang DR; Kent J; Simpson N; Parsey RV; Hashimoto T; Slifstein M; Huang Y; Van Heertum R; Abi-Dargham A; Caltabiano S; Malizia A; Cowley H; Mann JJ; Laruelle M
Nucl Med Biol; 2000 Jul; 27(5):523-7. PubMed ID: 10962261
[TBL] [Abstract][Full Text] [Related]
19. Is amoxapine an atypical antipsychotic? Positron-emission tomography investigation of its dopamine2 and serotonin2 occupancy.
Kapur S; Cho R; Jones C; McKay G; Zipursky RB
Biol Psychiatry; 1999 May; 45(9):1217-20. PubMed ID: 10331115
[TBL] [Abstract][Full Text] [Related]
20. Striatal and temporal cortical D2/D3 receptor occupancy by olanzapine and sertindole in vivo: a [123I]epidepride single photon emission tomography (SPET) study.
Bigliani V; Mulligan RS; Acton PD; Ohlsen RI; Pike VW; Ell PJ; Gacinovic S; Kerwin RW; Pilowsky LS
Psychopharmacology (Berl); 2000 Jun; 150(2):132-40. PubMed ID: 10907666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]